BiotechTube
Sage-N Research

Sage-N Research

Fremont, United States· Est.
sagenresearch.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Sage-N Research is a specialized AI/ML services and technology firm focused on the life sciences sector, particularly proteomics and biomarker discovery. Founded in 2000 and based in Fremont, California, the company has developed its proprietary AIMS™ platform, which combines artificial intelligence with mass spectrometry to reduce biomarker identification timelines from months or years to minutes. They operate primarily as a service provider, offering data engineering, integration, and AI implementation to support pharmaceutical and clinical research organizations. The company appears to be a private, revenue-generating entity serving the growing AI-in-biotech market.

AI / Machine Learning

Technology Platform

AIMS™ (Artificial Intelligence Mass Spectrometry) platform combining AI with mass spectrometry for accelerated biomarker discovery and proteomic analysis

Opportunities

Growing demand for AI in life sciences, increasing need for efficient biomarker discovery in personalized medicine, and expansion of mass spectrometry data complexity create significant market opportunities.
The company's specialized expertise at the intersection of AI and proteomics positions them well in a niche with high barriers to entry.

Risk Factors

Competition from large analytical instrument companies expanding into AI, potential slow adoption of AI methodologies in regulated research environments, and execution risk in delivering promised acceleration of biomarker discovery timelines.
Client concentration and data security compliance also present challenges.

Competitive Landscape

Competes with large analytical instrument manufacturers (Thermo Fisher, Agilent) developing AI capabilities, established bioinformatics software providers, and specialized AI-biotech platforms. Also faces competition from academic/open-source tools and internal bioinformatics teams at pharmaceutical companies.

More companies in AI / Machine Learning →More companies in United States →